| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
in Dendritic Cells Inhibits the Development of Eosinophilic Airway Inflammation in a Mouse Model of Asthma


From the Department of Pulmonary Medicine,* Erasmus Medical Center, Rotterdam, The Netherlands; and INSERM U547,
Institut Pasteur de Lille, Lille, France
Peroxisome proliferator-activated receptors (PPARs) are activated by an array of polyunsaturated fatty acid derivatives, oxidized fatty acids, and phospholipids and are proposed to be important modulators of immune and inflammatory responses. Recently, we showed that activation of PPAR-
alters the maturation process of dendritic cells (DCs), the most potent antigen-presenting cells. In the present report, we investigated the possibility that, by targeting DCs, PPAR-
activation may be involved in the regulation of the pulmonary immune response to allergens. Using a model of sensitization, based on the intratracheal transfer of ovalbumin (OVA)-pulsed DCs, we show that rosiglitazone, a selective PPAR-
agonist, reduces the proliferation of Ag-specific T cells in the draining mediastinal lymph nodes but, surprisingly enough, dramatically increases the production of the immunoregulatory cytokine interleukin (IL)-10 by T cells, as compared to control mice sensitized with OVA-pulsed DCs. After aerosol challenge, the recruitment of eosinophils in the bronchoalveolar lavage fluids was strongly reduced compared to control mice. Finally, T cells from the mediastinal lymph nodes produced higher amounts of IL-10 and interferon-
. Inhibition of IL-10 activity with anti-IL-10R antibodies partly restored the inflammation. The specificity of the phenomenon was confirmed by treating OVA-pulsed DCs with ciglitazone, another PPAR-
agonist, and by using GW9662, a PPAR-
antagonist. Our data suggest that PPAR-
activation prevents induction of Th2-dependent eosinophilic airway inflammation and might contribute to immune homeostasis in the lung.
This article has been cited by other articles:
![]() |
M. G. Belvisi and D. J. Hele Peroxisome Proliferator-Activated Receptors as Novel Targets in Lung Disease Chest, July 1, 2008; 134(1): 152 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miksa, R. Wu, X. Cui, W. Dong, P. Das, H. H. Simms, T. S. Ravikumar, and P. Wang Vasoactive Hormone Adrenomedullin and Its Binding Protein: Anti-Inflammatory Effects by Up-Regulating Peroxisome Proliferator-Activated Receptor-{gamma} J. Immunol., November 1, 2007; 179(9): 6263 - 6272. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Marathe and P. Tontonoz Linking metabolism to immunity through PPAR{gamma} Blood, November 1, 2007; 110(9): 3092 - 3093. [Full Text] [PDF] |
||||
![]() |
E. A. Wohlfert, F. C. Nichols, E. Nevius, and R. B. Clark Peroxisome Proliferator-Activated Receptor {gamma} (PPAR{gamma}) and Immunoregulation: Enhancement of Regulatory T Cells through PPAR{gamma}-Dependent and -Independent Mechanisms J. Immunol., April 1, 2007; 178(7): 4129 - 4135. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hontecillas and J. Bassaganya-Riera Peroxisome Proliferator-Activated Receptor {gamma} Is Required for Regulatory CD4+ T Cell-Mediated Protection against Colitis J. Immunol., March 1, 2007; 178(5): 2940 - 2949. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gogolak, B. Rethi, I. Szatmari, A. Lanyi, B. Dezso, L. Nagy, and E. Rajnavolgyi Differentiation of CD1a- and CD1a+ monocyte-derived dendritic cells is biased by lipid environment and PPAR{gamma} Blood, January 15, 2007; 109(2): 643 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. SZATMARI, E. RAJNAVOLGYI, and L. NAGY PPAR{gamma}, a Lipid-Activated Transcription Factor as a Regulator of Dendritic Cell Function Ann. N.Y. Acad. Sci., November 1, 2006; 1088(1): 207 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Simon, M. C. Arikan, S. Srisuma, S. Bhattacharya, L. W. Tsai, E. P. Ingenito, F. Gonzalez, S. D. Shapiro, and T. J. Mariani Epithelial cell PPAR{gamma} contributes to normal lung maturation FASEB J, July 1, 2006; 20(9): 1507 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jakubzick, F. Tacke, J. Llodra, N. van Rooijen, and G. J. Randolph Modulation of Dendritic Cell Trafficking to and from the Airways J. Immunol., March 15, 2006; 176(6): 3578 - 3584. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. August, C. Mueller, V. Weaver, T. A. Polanco, E. R. Walsh, and M. T. Cantorna Nutrients, Nuclear Receptors, Inflammation, Immunity Lipids, PPAR, and Allergic Asthma J. Nutr., March 1, 2006; 136(3): 695 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Kim, K. S. Lee, H. S. Park, S. J. Park, K. H. Min, S. M. Jin, and Y. C. Lee Involvement of IL-10 in Peroxisome Proliferator-Activated Receptor {gamma}-Mediated Anti-Inflammatory Response in Asthma Mol. Pharmacol., December 1, 2005; 68(6): 1568 - 1575. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, R. Han, I. Lee, A. S. Hancock, G. Xiong, M. D. Gunn, and W. W. Hancock Permanent Survival of Fully MHC-Mismatched Islet Allografts by Targeting a Single Chemokine Receptor Pathway J. Immunol., November 15, 2005; 175(10): 6311 - 6318. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Henry, A. D'Aprile, G. Self, T. Hong, and T. S. Mann Inhibitors of Prostaglandin Transport and Metabolism Augment Protease-Activated Receptor-2-Mediated Increases in Prostaglandin E2 Levels and Smooth Muscle Relaxation in Mouse Isolated Trachea J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 995 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Fainaru, D. Shseyov, S. Hantisteanu, and Y. Groner Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease PNAS, July 26, 2005; 102(30): 10598 - 10603. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Visser, H. Jan de Heer, L. A. Boven, D. van Riel, M. van Meurs, M.-J. Melief, U. Zahringer, J. van Strijp, B. N. Lambrecht, E. E. Nieuwenhuis, et al. Proinflammatory Bacterial Peptidoglycan as a Cofactor for the Development of Central Nervous System Autoimmune Disease J. Immunol., January 15, 2005; 174(2): 808 - 816. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |